| 000 | 01875cam a2200361 a 4500 | ||
|---|---|---|---|
| 003 | EG-GiCUC | ||
| 005 | 20250223030200.0 | ||
| 008 | 100206s2009 ua d f m 000 0 eng d | ||
| 040 |
_aEG-GiCUC _beng _cEG-GiCUC |
||
| 041 | 0 | _aeng | |
| 049 | _aDeposite | ||
| 097 | _aPh.D | ||
| 099 | _aCai01.11.23.Ph.D.2009.Ra.P | ||
| 100 | 0 | _aRaafat Ragaie Abdelmalek | |
| 245 | 1 | 0 |
_aPaclitaxel/carboplatin versus carboplatin in patients with epithelial ovarian cancer and correlation to serum marker VEGF / _cRaafat Ragaie Abdelmalek ; Supervised Wafaa Hassan Elmetnawy , Yasser Salah Abdelkader , Emad Mahmoud Hamada |
| 246 | 1 | 5 | _aمقارنة بين استخدام عقارى باكليتاكسيل مع كاربوبلاتين و عقار كاربوبلاتين بمفرده فى علاج حالات سرطان المبيض و علاقته بمستوى عامل نمو خلايا الأوعية الدموية بالدم |
| 260 |
_aCairo : _bRaafat Ragaie Abdelmalek , _c2009 |
||
| 300 |
_a112 P. : _bcharts ; _c25cm |
||
| 502 | _aThesis (Ph.D.) - Cairo University - Faculty of Medicine - Department of Oncology-Clinical | ||
| 520 | _aThis study is a prospective non-randomized study including 50 patients with established diagnosis of epithelial ovarian carcinoma attending Kasr Eleiny centre of clinical oncology (NEMROCK) in the period from January 2006 to December 2007 inclusive. After complete diagnosis and staging work up | ||
| 530 | _aIssued also as CD | ||
| 653 | 4 | _aAUC 7 | |
| 653 | 4 | _aOvarian carcinoma | |
| 653 | 4 | _aSingle agent carboplatin | |
| 700 | 0 |
_aEmad Mahmoud Hamada , _eSupervisor |
|
| 700 | 0 |
_aWafaa Hassan Elmetnawy , _eSupervisor |
|
| 700 | 0 |
_aYasser Salah Abdelkader , _eSupervisor |
|
| 856 | _uhttp://172.23.153.220/th.pdf | ||
| 902 | _a1 | ||
| 905 |
_aMustafa _eRevisor |
||
| 905 |
_aSamia _eCataloger |
||
| 942 |
_2ddc _cTH |
||
| 999 |
_c29347 _d29347 |
||